Fundraising Fox
bioProtonics
Santa Barbara, US · Founded 2018 · Delaware corporation
Find your way into bioProtonics
Each arrow is one introduction. Sign up to fill in the first one.
292 people can intro you to Joseph
Ask Stuart Hwang to introduce you to Joseph Fleming
You →Stuart · together at Paracel Inc. →Joseph
Sign up to find every way you can get introduced to bioProtonics
- Your email: who you already know at bioProtonics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the bioProtonics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
FF
Forrest FlemingChief Executive Officer2023–2025Forrest Fleming founded and led TrueVision Surgical (2006-2018), a digital surgery platform acquired by Alcon, and ScentAir Technologies (2000-2005), a scent-marketing company later acquired by Parthenon PE. He holds a B.S. in Industrial Technology from Cal Poly San Luis Obispo and has held senior sales and marketing roles at Parametric Technology, Paracel, and Cinesite.
DR
Daniel R. DoironExecutive
WT
W. Timothy JamesNamed on SEC filing
CW
Charles W WincklerNamed on SEC filing
Board
KL
Kristin LoomisBoard director
RS
Ryan ShieldsBoard director
TW
Timothy W. JamesBoard director
Reported raises · per SEC filings
Form D private placements$9.6M disclosed across 10 rounds · 2019–2025
▶$1MraisedApr 2026 · 6 investors · OtherRule 506(b)
▶$1MraisedApr 2026 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Timothy W. JamesDirector
- Kristin LoomisDirector
- A. Burton TripathiExecutive Officer, Director
- Ryan ShieldsDirector
- Daniel R. DoironExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $1M
- First sale
- Jul 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.7MraisedDec 2024 · 18 investors · OtherRule 506(b)
▶$2.7MraisedDec 2024 · 18 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Forrest FlemingExecutive Officer, Director
- Kristin LoomisDirector
- Ryan ShieldsDirector
- Daniel R. DoironExecutive Officer, Director
- Timothy W. JamesDirector
- Offering amount
- $2.7M
- Amount sold
- $2.7M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedApr 2024 · 13 investors · OtherRule 506(b)
▶$1.9MraisedApr 2024 · 13 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Ryan ShieldsDirector
- KRISTIN LOOMISDirector
- Forrest FlemingExecutive Officer, Director
- TIMOTHY W. JAMESDirector
- DANIEL R. DOIRONExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $1.9M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$74.4KraisedApr 2023 · 1 investors · OtherRule 506(b)
▶$74.4KraisedApr 2023 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Forrest FlemingExecutive Officer
- Timothy W. JamesDirector
- Daniel R. DoironExecutive Officer, Director
- Kristin LoomisDirector
- Offering amount
- $74.4K
- Amount sold
- $74.4K
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$108.9KraisedJan 2023 · 3 investors · OtherRule 506(b)
▶$108.9KraisedJan 2023 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Daniel R. DoironExecutive Officer, Director
- Kristin LoomisDirector
- Timothy W. JamesDirector
- Forrest FlemingExecutive Officer
- Offering amount
- $108.9K
- Amount sold
- $108.9K
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$1MraisedAug 2021 · 5 investors · OtherRule 506(b)
▶$1MraisedAug 2021 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Charles W. WincklerExecutive Officer
- Timothy JamesDirector
- Kristin LoomisDirector
- Daniel R. DoironExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$837KraisedJul 2021 · 6 investors · OtherRule 506(b)
▶$837KraisedJul 2021 · 6 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- W. Timothy JamesDirector
- Kristin LoomisDirector
- Daniel R. DoironExecutive Officer, Director
- Charles W WincklerExecutive Officer
- Offering amount
- $1M
- Amount sold
- $837K
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$577KraisedMar 2021 · 4 investors · OtherRule 506(b)
▶$577KraisedMar 2021 · 4 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Daniel R. DoironExecutive Officer, Director
- W. Timothy JamesDirector
- Kristin LoomisDirector
- Charles W WincklerExecutive Officer
- Offering amount
- $1M
- Amount sold
- $577K
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2016 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- How much funding has bioProtonics raised?
- bioProtonics has disclosed $9.6M raised across 10 rounds.
- Where is bioProtonics headquartered?
- bioProtonics is headquartered in Santa Barbara, US.